Mostafa M. S. Shelkamy, Amro Hashish, Mariela E. Srednik, Maria Chaves, Nubia R. Macedo, Eman Gadu, Stephan Schmitz-Esser, Qijing Zhang, Chong Wang, Yuko Sato, Mohamed El-Gazzar
{"title":"Prevalence of Nonpathogenic Avibacterium paragallinarum in Naïve-Healthy Layer Flocks Across Multiple States in the United States","authors":"Mostafa M. S. Shelkamy, Amro Hashish, Mariela E. Srednik, Maria Chaves, Nubia R. Macedo, Eman Gadu, Stephan Schmitz-Esser, Qijing Zhang, Chong Wang, Yuko Sato, Mohamed El-Gazzar","doi":"10.1155/tbed/9994679","DOIUrl":null,"url":null,"abstract":"<div>\n <p>Infectious coryza (IC) caused by <i>Avibacterium paragallinarum</i> (AP) is an emerging infectious respiratory disease in the commercial chicken layer industry in the Midwestern US states. Outbreak investigations around positive index cases led to the discovery of nonpathogenic AP (npAP), which caused quantitative real-time PCR (qPCR) positive results in naïve-healthy layer (NHL) flocks. Therefore, the reliability of positive qPCR as confirmed diagnosis of IC became questionable and the poultry industry was deprived from an essential diagnostic tool in the face of an actively spreading outbreak. However, the prevalence of npAP in NHL flocks and the magnitude of this diagnostic challenge remained unclear. This pilot surveillance study aims to provide an initial estimate of npAP prevalence in the US commercial layer industry. Two differential qPCR assays were recently developed to differentiate pathogenic AP (pAP) and npAP. A total of 710 oropharyngeal (OP) swab pools (5 swabs/pool) were collected from 80 NHL sites across 13 US states and tested using qPCR assay targeting the <i>recN</i> gene as a screening test. Two hundred thirty-one out of 710 total pools were positive for npAP (32.5%) representing 28 positive sites out of the 80 total sites (35%). All positive qPCR samples from NHL flocks were confirmed to be due npAP. The differential qPCR was capable of confirming 85.71% of the npAP cases, while the remaining cases required further isolation and whole-genome sequencing (WGS). In conclusion, this pilot study indicates that the prevalence of npAP in NHL flocks in the United States is above 30%. Therefore, in flocks with no clinical signs, qPCR assays cannot be relied upon for IC diagnostic confirmation. Currently, isolation combined with WGS is the only diagnostic tool capable of completely differentiating between these two AP populations, which indicates the immediate need for improvements in the available diagnostic assays.</p>\n </div>","PeriodicalId":234,"journal":{"name":"Transboundary and Emerging Diseases","volume":"2025 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/tbed/9994679","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transboundary and Emerging Diseases","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/tbed/9994679","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Infectious coryza (IC) caused by Avibacterium paragallinarum (AP) is an emerging infectious respiratory disease in the commercial chicken layer industry in the Midwestern US states. Outbreak investigations around positive index cases led to the discovery of nonpathogenic AP (npAP), which caused quantitative real-time PCR (qPCR) positive results in naïve-healthy layer (NHL) flocks. Therefore, the reliability of positive qPCR as confirmed diagnosis of IC became questionable and the poultry industry was deprived from an essential diagnostic tool in the face of an actively spreading outbreak. However, the prevalence of npAP in NHL flocks and the magnitude of this diagnostic challenge remained unclear. This pilot surveillance study aims to provide an initial estimate of npAP prevalence in the US commercial layer industry. Two differential qPCR assays were recently developed to differentiate pathogenic AP (pAP) and npAP. A total of 710 oropharyngeal (OP) swab pools (5 swabs/pool) were collected from 80 NHL sites across 13 US states and tested using qPCR assay targeting the recN gene as a screening test. Two hundred thirty-one out of 710 total pools were positive for npAP (32.5%) representing 28 positive sites out of the 80 total sites (35%). All positive qPCR samples from NHL flocks were confirmed to be due npAP. The differential qPCR was capable of confirming 85.71% of the npAP cases, while the remaining cases required further isolation and whole-genome sequencing (WGS). In conclusion, this pilot study indicates that the prevalence of npAP in NHL flocks in the United States is above 30%. Therefore, in flocks with no clinical signs, qPCR assays cannot be relied upon for IC diagnostic confirmation. Currently, isolation combined with WGS is the only diagnostic tool capable of completely differentiating between these two AP populations, which indicates the immediate need for improvements in the available diagnostic assays.
期刊介绍:
Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):
Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.
Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.
Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.
Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).
Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.